Terms: = Skin cancer AND FGFR2, BFR-1, 2263, ENSG00000066468, TK14, BEK, CD332, JWS, TK25, ECT1, CEK3, K-SAM, CFD1, KGFR AND Prognosis
3 results:
1. Molecular characterization of fast-growing melanomas.
Gaudy-Marqueste C; Macagno N; Loundou A; Pellegrino E; Ouafik L; Budden T; Mundra P; Gremel G; Akhras V; Lin L; Cook M; Kumar R; Grob JJ; Nagore E; Marais R; Virós A
J Am Acad Dermatol; 2022 Feb; 86(2):312-321. PubMed ID: 34280484
[TBL] [Abstract] [Full Text] [Related]
2. Cerebriform sebaceous nevus: a subtype of organoid nevus due to specific postzygotic fgfr2 mutations.
Theiler M; Weibel L; Christen-Zaech S; Carmignac V; Sorlin A; Neuhaus K; Chevarin M; Thauvin-Robinet C; Philippe C; Faivre L; Vabres P; Kuentz P
J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):2085-2090. PubMed ID: 33930231
[TBL] [Abstract] [Full Text] [Related]
3. Pembrolizumab in Patients with Advanced Metastatic Germ Cell Tumors.
Tsimberidou AM; Vo HH; Subbiah V; Janku F; Piha-Paul S; Yilmaz B; Gong J; Naqvi MF; Tu SM; Campbell M; Meric-Bernstam F; Naing A
Oncologist; 2021 Jul; 26(7):558-e1098. PubMed ID: 33491277
[TBL] [Abstract] [Full Text] [Related]
